Epidermal il-15Rα acts as an endogenous antagonist of psoriasiform inflammation in mouse and man

Journal of Experimental Medicine

Volumn 210, Issue 10, 2013, Pages 2105-2117

  Bouchaud, Grégory ^a   Gehrke, Samuel ^a   Krieg, Carsten ^a   Kolios, Antonios ^a   Hafner, Jürg ^a   Navarini, Alexander A ^a   French, Lars E ^a   Boyman, Onur ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALPHA BETA T LYMPHOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; EPIDERMIS CELL; FEMALE; GAMMA DELTA T LYMPHOCYTE; HUMAN; IN VIVO STUDY; KERATINOCYTE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PSORIASIS; STROMA CELL; T LYMPHOCYTE;

ADULT; ANIMALS; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; EPIDERMIS; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-15; INTERLEUKIN-15 RECEPTOR ALPHA SUBUNIT; KERATINOCYTES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; PSORIASIS; STROMAL CELLS; T-LYMPHOCYTE SUBSETS;

EID: 84885450668     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20130291     Document Type: Article

References (44)

1. Barker, J.N., R.S. Mitra, C.E. Griffiths, V.M. Dixit, and B.J. Nickoloff. 1991. Keratinocytes as initiators of inflammation. Lancet. 337:211-214. http://dx.doi.org/10.1016/0140-6736(91)92168-2
2. Baslund, B., N. Tvede, B. Danneskiold-Samsoe, P. Larsson, G. Panayi, J. Petersen, L.J. Petersen, F.J. Beurskens, J. Schuurman, J.G. van de Winkel, et al. 2005. Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis Rheum. 52:2686-2692. http://dx.doi.org/10.1002/art.21249
3. Bouchaud, G., L. Garrigue-Antar, V. Solé, A. Quéméner, Y. Boublik, E. Mortier, H. Perdreau, Y. Jacques, and A. Plet. 2008. The exon-3-encoded domain of IL-15ralpha contributes to IL-15 high-affinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Ralpha. J. Mol. Biol. 382:1-12. http://dx.doi.org/10.1016/j.jmb.2008.07.019
4. Bouchaud, G., E. Mortier, M. Flamant, I. Barbieux, A. Plet, J.P. Galmiche, Y. Jacques, and A. Bourreille. 2010. Interleukin-15 and its soluble receptor mediate the response to infliximab in patients with Crohn's disease. Gastroenterology. 138:2378-2387. http://dx.doi.org/10.1053/j.gastro.2010.02.044
5. Boyman, O., H.P. Hefti, C. Conrad, B.J. Nickoloff, M. Suter, and F.O. Nestle. 2004. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-α. J. Exp. Med. 199:731-736. http://dx.doi.org/10.1084/jem.20031482
6. Boyman, O., C. Conrad, G. Tonel, M. Gilliet, and F.O. Nestle. 2007. The pathogenic role of tissue-resident immune cells in psoriasis. Trends Immunol. 28:51-57. http://dx.doi.org/10.1016/j.it.2006.12.005
7. Boyman, O., C. Krieg, D. Homann, and J. Sprent. 2012. Homeostatic maintenance of T cells and natural killer cells. Cell. Mol. Life Sci. 69:1597-1608. http://dx.doi.org/10.1007/s00018-012-0968-7
8. Burkett, P.R., R. Koka, M. Chien, S. Chai, D.L. Boone, and A. Ma. 2004. Coordinate expression and trans presentation of interleukin (IL)-15Rα and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis. J. Exp. Med. 200:825-834. http://dx.doi.org/10.1084/jem.20041389
9. Cai, Y., X. Shen, C. Ding, C. Qi, K. Li, X. Li, V.R. Jala, H.G. Zhang, T. Wang, J. Zheng, and J. Yan. 2011. Pivotal role of dermal IL-17-producing αα T cells in skin inflammation. Immunity. 35:596-610. http://dx.doi.org/10.1016/j.immuni.2011.08.001
10. Chaudhari, U., P. Romano, L.D. Mulcahy, L.T. Dooley, D.G. Baker, and A.B. Gottlieb. 2001. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet. 357:1842-1847. http://dx.doi.org/10.1016/S0140-6736(00)04954-0
11. Conrad, C., O. Boyman, G. Tonel, A. Tun-Kyi, U. Laggner, A. de Fougerolles, V. Kotelianski, H. Gardner, and F.O. Nestle. 2007. Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis. Nat. Med. 13:836-842. http://dx.doi.org/10.1038/nm1605
12. Di Meglio, P., G.K. Perera, and F.O. Nestle. 2011. The multitasking organ: recent insights into skin immune function. Immunity. 35:857-869. http://dx.doi.org/10.1016/j.immuni.2011.12.003
13. Dubois, S., F. Magrangeas, P. Lehours, S. Raher, J. Bernard, O. Boisteau, S. Leroy, S. Minvielle, A. Godard, and Y. Jacques. 1999. Natural splicing of exon 2 of human interleukin-15 receptor alpha-chain mRNA results in a shortened form with a distinct pattern of expression. J. Biol. Chem. 274:26978-26984. http://dx.doi.org/10.1074/jbc.274.38.26978
14. Dubois, S., J. Mariner, T.A. Waldmann, and Y. Tagaya. 2002. IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity. 17:537-547. http://dx.doi.org/10.1016/S1074-7613(02)00429-6
15. Gilliet, M., C. Conrad, M. Geiges, A. Cozzio, W. Thürlimann, G. Burg, F.O. Nestle, and R. Dummer. 2004. Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch. Dermatol. 140:1490-1495. http://dx.doi.org/10.1001/archderm.140.12.1490
16. Hoeve, M.A., N.D. Savage, T. de Boer, D.M. Langenberg, R. de Waal Malefyt, T.H. Ottenhoff, and F.A. Verreck. 2006. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur. J. Immunol. 36:661-670. http://dx.doi.org/10.1002/eji.200535239
17. Jung, S., D. Unutmaz, P. Wong, G. Sano, K. De los Santos, T. Sparwasser, S. Wu, S. Vuthoori, K. Ko, F. Zavala, et al. 2002. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity. 17:211-220. http://dx.doi.org/10.1016/S1074-7613(02)00365-5
18. Kennedy, M.K., M. Glaccum, S.N. Brown, E.A. Butz, J.L. Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C.R. Willis, et al. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191:771-780. http://dx.doi.org/10.1084/jem.191.5.771
19. Khan, I.A., M. Moretto, X.Q. Wei, M. Williams, J.D. Schwartzman, and F.Y. Liew. 2002. Treatment with soluble interleukin-15Rα exacerbates intracellular parasitic infection by blocking the development of memory CD8+ T cell response. J. Exp. Med. 195:1463-1470. http://dx.doi.org/10.1084/jem.20011915
20. Kissenpfennig, A., S. Henri, B. Dubois, C. Laplace-Builhé, P. Perrin, N. Romani, C.H. Tripp, P. Douillard, L. Leserman, D. Kaiserlian, et al. 2005. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity. 22:643-654. http://dx.doi.org/10.1016/j.immuni.2005.04.004
21. Krieg, C., S. Létourneau, G. Pantaleo, and O. Boyman. 2010. Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells. Proc. Natl. Acad. Sci. USA. 107:11906-11911. http://dx.doi.org/10.1073/pnas.1002569107
22. Krueger, J.G. 2012. Hiding under the skin: A welcome surprise in psoriasis. Nat. Med. 18:1750-1751. http://dx.doi.org/10.1038/nm.3025
23. Laggner, U., P. Di Meglio, G.K. Perera, C. Hundhausen, K.E. Lacy, N. Ali, C.H. Smith, A.C. Hayday, B.J. Nickoloff, and F.O. Nestle. 2011. Identification of a novel proinflammatory human skin-homing Vα9Vα2 T cell subset with a potential role in psoriasis. J. Immunol. 187:2783-2793. http://dx.doi.org/10.4049/jimmunol.1100804
24. Lande, R., J. Gregorio, V. Facchinetti, B. Chatterjee, Y.H. Wang, B. Homey, W. Cao, Y.H. Wang, B. Su, F.O. Nestle, et al. 2007. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 449:564-569. http://dx.doi.org/10.1038/nature06116
25. Leonardi, C., R. Matheson, C. Zachariae, G. Cameron, L. Li, E. Edson-Heredia, D. Braun, and S. Banerjee. 2012. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N. Engl. J. Med. 366:1190-1199. http://dx.doi.org/10.1056/NEJMoa1109997
26. Lodolce, J.P., D.L. Boone, S. Chai, R.E. Swain, T. Dassopoulos, S. Trettin, and A. Ma. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity. 9:669-676. http://dx.doi.org/10.1016/S1074-7613(00)80664-0
27. Lowes, M.A., A.M. Bowcock, and J.G. Krueger. 2007. Pathogenesis and therapy of psoriasis. Nature. 445:866-873. http://dx.doi.org/10.1038/nature05663
28. McInnes, I.B., and F.Y. Liew. 1998. Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis. Immunol. Today. 19:75-79. http://dx.doi.org/10.1016/S0167-5699(97)01205-X
29. Mease, P.J., B.S. Goffe, J. Metz, A. VanderStoep, B. Finck, and D.J. Burge. 2000. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet. 356:385-390. http://dx.doi.org/10.1016/S0140-6736(00)02530-7
30. Merad, M., M.G. Manz, H. Karsunky, A. Wagers, W. Peters, I. Charo, I.L. Weissman, J.G. Cyster, and E.G. Engleman. 2002. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3:1135-1141. http://dx.doi.org/10.1038/ni852
31. Nestle, F.O., C. Conrad, A. Tun-Kyi, B. Homey, M. Gombert, O. Boyman, G. Burg, Y.J. Liu, and M. Gilliet. 2005. Plasmacytoid predendritic cells initiate psoriasis through interferon-α production. J. Exp. Med. 202:135-143. http://dx.doi.org/10.1084/jem.20050500
32. Nestle, F.O., D.H. Kaplan, and J. Barker. 2009. Psoriasis. N. Engl. J. Med. 361:496-509. http://dx.doi.org/10.1056/NEJMra0804595
33. Nguyen, K.B., T.P. Salazar-Mather, M.Y. Dalod, J.B. Van Deusen, X.Q. Wei, F.Y. Liew, M.A. Caligiuri, J.E. Durbin, and C.A. Biron. 2002. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169:4279-4287.
34. Pantelyushin, S., S. Haak, B. Ingold, P. Kulig, F.L. Heppner, A.A. Navarini, and B. Becher. 2012. Rorαt+ innate lymphocytes and αα T cells initiate psoriasiform plaque formation in mice. J. Clin. Invest. 122:2252-2256. http://dx.doi.org/10.1172/JCI61862
35. Papp, K.A., C. Leonardi, A. Menter, J.P. Ortonne, J.G. Krueger, G. Kricorian, G. Aras, J. Li, C.B. Russell, E.H. Thompson, and S. Baumgartner. 2012. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N. Engl. J. Med. 366:1181-1189. http://dx.doi.org/10.1056/NEJMoa1109017
36. Rubinstein, M.P., M. Kovar, J.F. Purton, J.H. Cho, O. Boyman, C.D. Surh, and J. Sprent. 2006. Converting IL-15 to a superagonist by binding to soluble IL-15Ralpha. Proc. Natl. Acad. Sci. USA. 103:9166-9171. http://dx.doi.org/10.1073/pnas.0600240103
37. Ruchatz, H., B.P. Leung, X.Q. Wei, I.B. McInnes, and F.Y. Liew. 1998. Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigeninduced immunopathology. J. Immunol. 160:5654-5660.
38. Rückert, R., K. Asadullah, M. Seifert, V.M. Budagian, R. Arnold, C. Trombotto, R. Paus, and S. Bulfone-Paus. 2000. Inhibition of keratinocyte apoptosis by IL-15: a new parameter in the pathogenesis of psoriasisα J. Immunol. 165:2240-2250.
39. Schluns, K.S., K.D. Klonowski, and L. Lefrançois. 2004. Transregulation of memory CD8 T-cell proliferation by IL-15Ralpha+ bone marrow-derived cells. Blood. 103:988-994. http://dx.doi.org/10.1182/blood-2003-08-2814
40. Stoklasek, T.A., K.S. Schluns, and L. Lefrançois. 2006. Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo. J. Immunol. 177:6072-6080.
41. Tortola, L., E. Rosenwald, B. Abel, H. Blumberg, M. Schäfer, A.J. Coyle, J.C. Renauld, S. Werner, J. Kisielow, and M. Kopf. 2012. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J. Clin. Invest. 122:3965-3976. http://dx.doi.org/10.1172/JCI63451
42. van der Fits, L., S. Mourits, J.S. Voerman, M. Kant, L. Boon, J.D. Laman, F. Cornelissen, A.M. Mus, E. Florencia, E.P. Prens, and E. Lubberts. 2009. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J. Immunol. 182:5836-5845. http://dx.doi.org/10.4049/jimmunol.0802999
43. Villadsen, L.S., J. Schuurman, F. Beurskens, T.N. Dam, F. Dagnaes-Hansen, L. Skov, J. Rygaard, M.M. Voorhorst-Ogink, A.F. Gerritsen, M.A. van Dijk, et al. 2003. Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. J. Clin. Invest. 112:1571-1580.
44. Waldmann, T.A., and Y. Tagaya. 1999. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu. Rev. Immunol. 17:19-49. http://dx.doi.org/10.1146/annurev.immunol.17.1.19